| Application no. and date | 13750725.7 (espacenet) (Federated) (European Patent Register), 20130822 | | Patent/reg. no. and date | DK/EP 2887961, 20210428 | | Publication date | 20150701 | | Priority no. and date | US 201261692911 P, 20120824 | | EP pub. no. and date |
EP 2887961 20150701 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | BT/GP/164823 | | Inventor | SCHUMACHER, Christoph, c/o Novartis Pharma AG
Postfach
CH-4002 Basel, CH,
HOLBRO, Thomas, c/o Novartis Pharma AG
Postfach
CH-4002 Basel, CH | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/194 (2006.01) , A61K 31/197 (2006.01) , A61K 31/216 (2006.01) , A61K 31/41 (2006.01) , A61K 31/4192 (2006.01) , A61K 45/06 (2006.01) , A61P 43/00 (2006.01) , A61P 7/00 (2006.01) , A61P 9/00 (2006.01) , A61P 9/04 (2006.01) , A61P 9/06 (2006.01) , A61P 9/10 (2006.01) , A61P 9/12 (2006.01) | | Title | NEP-INHIBITORER TIL BEHANDLING AF SYGDOMME, DER ER KENDETEGNET VED ATRIEFORSTØRRELSE ELLER -REMODELLERING | | Int. application no. | EP2013067472 | | Int. publication no. | WO2014029848 | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
